Keiji Fukuda, the special adviser to the WHO director general on pandemic influenza, on Thursday dismissed allegations that the agency exaggerated the threat of the H1N1 (swine flu) pandemic and has been influenced by the pharmaceutical industry, the Washington Post reports. Fukuda’s defense came amid reports this week that the Council of Europe will investigate the WHO’s actions and as several countries slash H1N1 vaccine orders.
Amid recent complaints that the WHO exaggerated the threat of the H1N1 (swine flu) virus, the agency announced Tuesday an upcoming independent review of the agency’s handling of the pandemic, Agence France-Presse reports (1/12).
A $27 million UNICEF program that aims to decrease disease-related child deaths in West Africa did not meet its goal of reducing death rates by at least 25 percent at the conclusion of 2006, according to a Lancet study published on Tuesday, the Associated Press reports. “The U.N. children’s agency pursued strategies like vaccinating children, giving them vitamin A pills and distributing bednets to protect against malaria from 2001 to 2005 in parts of 11 countries,” according to the article.
Media Outlets Examine U.S. Plans For Leftover H1N1 Vaccine, Efforts To Keep Flu Vaccine Production On Track
After working to ensure the U.S. had access to enough H1N1 (swine flu) vaccine, health officials may now face a new dilemma â€“ a vaccine surplus, the Associated Press reports. “Get ready for a huge flu-shot push as health officials try to rekindle interest in protection against this new influenza strain that, despite plummeting cases, still is threatening lives â€“ even as they reassess just how much more vaccine needs to be shipped,” the news service writes.
Also In Global Health News: Dengue Vaccine; Medicines For Poor; Gates New Ag Development Director; USDA Efforts In Afghanistan; Soccer And Malaria
Experimental Dengue Vaccine Shows Promise In Clinical Trial Of Adults An experimental dengue vaccine created by the drugmaker Sanofi-Aventis protected a group of healthy adults from all four strains of the virus, “bringing the drugmaker closer to providing the first vaccine against a disease that threatens 40 percent of the…
H1N1 (swine flu) has killed 12,799 people worldwide since the virus first emerged, the WHO said on Friday, United Press International reports (1/8). According to the WHO, more than half of the H1N1-related deaths worldwide occurred in the Americas, China Daily reports (1/9).
In a story about polio vaccination campaigns in Afghanistan, the Wall Street Journal examines how the Taliban and international health agencies are working together to promote oral vaccination campaigns across the country. Vaccination campaign volunteers usually bring a “single-page letter requesting people to cooperate, ‘for the benefit of our next generations.’ The letter’s signatory: Mullah Mohammad Omar, the one-eyed supreme leader of the Taliban,” according to the Wall Street Journal.
CDC Encourages Public To Receive H1N1 Vaccine; PBS Examines Arrival Of Vaccine In Developing Countries
During a media briefing Thursday, Anne Schuchat, director of the National Center for Immunization and Respiratory Diseases at the CDC, warned against complacency over the H1N1 (swine flu), and encouraged Americans who had not yet received the H1N1 vaccine to do so, CNN reports.
Canadian Health Minister Leona Aglukkaq on Wednesday announced plans for the country to loan Mexico five million doses of the H1N1 (swine flu) vaccine, Agence France-Presse reports. The loan will help Mexico meet its innoculation demand, while the country waits for H1N1 vaccine orders to be fulfilled by several manufacturers.
As the number of H1N1 (swine flu) cases in some regions of the world continues to fall, developing countries scheduled to receive donated H1N1 (swine flu) vaccines from the WHO are reassessing just how much vaccines their countries need, the Canadian Press reports. “The WHO had hoped to provide vaccine for up to 10 per cent of the populations of developing countries that wanted donated vaccine,” the newspaper writes.